Alessandro Sette

La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery

La Jolla, CA 92037

United States

  • La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery

SCHOLARLY PAPERS

12

DOWNLOADS

800

TOTAL CITATIONS

22

Scholarly Papers (12)

Actions:
Email selected abstracts
1.

'One Year Later' - SARS-CoV-2-Specific Immunity in Mild Cases of COVID-19

Number of pages: 29 Posted: 15 Jun 2021
Pablo Garcia Valtanen, Christopher M. Hope, Makutiro G Masavuli, Arthur Yeow, Harikrishnan Balachandran, Zelalem A. Mekonnen, Zahraa Al-Delfi, Arunasingam Abayasingam, David Agapiou, Jason Gummow, Catherine Ferguson, Stephanie O’Connor, Erin M. McCartney, David J Lynn, Guy Maddern, Eric J Gowans, Benjamin AJ Reddi, David Shaw, Kok-Lim Chuan, Michael Beard, Daniela Weiskopf, Alessandro Sette, Rowena Anne Bull, Simon C. Barry and Branka Grubor-Bauk
University of Adelaide, University of Adelaide, University of Adelaide, University of Adelaide - Viral Immunology Group, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of Adelaide, University of Adelaide, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of Adelaide, Royal Adelaide Hospital, Royal Adelaide Hospital, Royal Adelaide Hospital, South Australian Health and Medical Research Institute, University of Adelaide, University of Adelaide, Royal Adelaide Hospital, Royal Adelaide Hospital, Royal Adelaide Hospital, University of Adelaide, La Jolla Institute for Immunology - Center for Infectious Disease and Vaccine Research, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, University of New South Wales (UNSW) - Kirby Institute, University of Adelaide - Molecular Immunology and University of Adelaide - Viral Immunology Group
Downloads 202 (298,120)
Citation 2

Abstract:

Loading...

2.

Immune Responses Associated with Mpox Viral Clearance in a Prospective Observational Cohort of People with and Without HIV in Spain

Number of pages: 28 Posted: 22 Sep 2023
Igor Moraes-Cardoso, Susana Benet, Julieta Carabelli, Daniel Perez-Zsolt, Adrià Mendoza, Ángel Rivero, Andrea Alemany, Vicente Descalzo, Yovaninna Alarcón-Soto, Alba Grifoni, Alessandro Sette, José Moltó, Aurelien Marc, Michael Marks, Oriol Mitja, Christian Brander, Roger Paredes, Nuria Izquierdo-Useros, Jorge Carrillo, Clara Suñer, Alex Olvera and Beatriz Mothe
Hospital Universitari Germans Trias i Pujol - IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol - IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol - IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol - IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol - Skin Neglected Diseases and Sexually Transmitted Infections Section, Hospital Universitari Germans Trias i Pujol - Skin Neglected Diseases and Sexually Transmitted Infections Section, Hospital Universitari Germans Trias i Pujol - Skin Neglected Diseases and Sexually Transmitted Infections Section, Hospital Universitari Vall d’Hebron - Infectious Disease Department, Hospital Universitari Germans Trias i Pujol - Infectious Diseases Department, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, Hospital Universitari Germans Trias i Pujol - IrsiCaixa AIDS Research Institute, Université de Paris Cité - INSERM, London School of Hygiene & Tropical Medicine - Department of Clinical Research, Hospital Germans Trias i Pujol - Sexually Transmitted Infections and Skin Neglected Tropical Diseases Section, Universitat Autònoma de Barcelona, Hospital Universitari Germans Trias i Pujol - Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol - IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol - IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol - Skin Neglected Diseases and Sexually Transmitted Infections Section, Hospital Universitari Germans Trias i Pujol - IrsiCaixa AIDS Research Institute and IrsiCaixa AIDS Research Institute-HIVACAT
Downloads 114 (478,736)
Citation 1

Abstract:

Loading...

monkeypox, monkeypox virus, MPXV, mpox, natural immunity, mpox antibodies, mpox T-cells, mpox viral clearance, mpox severity, PWH, HIV

3.

Candidate Targets for Immune Responses to 2019-Novel Coronavirus (nCoV): Sequence Homology- and Bioinformatic-Based Predictions

Number of pages: 31 Posted: 25 Feb 2020
Alba Grifoni, John Sidney, Yun Zhang, Richard H. Scheuermann, Bjoern Peters and Alessandro Sette
La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, J. Craig Venter Institute, California, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery and La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery
Downloads 108 (498,073)
Citation 9

Abstract:

Loading...

SARS-CoV, COVID-19, 2019-nCoV, coronavirus, T cell epitope, B cell epitope, infectious disease, sequence conservation

4.

Immunogenicity of MVA-BN Vaccine Deployed as Mpox Prophylaxis: A Prospective Cohort Study and Analysis of Transcriptomic Predictors of Response

Number of pages: 32 Posted: 16 Sep 2024
Philip G. Drennan, Nicholas Provine, Stephanie A. Harris, Ashley Otter, Jekaterina Hollett, Cushla Cooper, Roel PH De Maeyer, Beatrice Nassanga, Alberta Ateere, Maria Fransiska Pudjohartono, Yanchun Peng, Ji-Li Chen, Scott Jones, Nurul Huda Mohamad Fadzillah, Alba Grifoni, Alessandro Sette, Iman Satti, Sam M. Murray, Cathy Rowe, Sema Mandal, Bassam Hallis, Paul Klenerman, Tao Dong, Duncan Richards, James Fullerton, Helen McShane and Mark Coles
University of Oxford, University of Oxford, University of Oxford, UK Health Security Agency - Rare & Imported Pathogens Laboratory, University of Oxford, University of Oxford, University of Oxford, Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM), Uganda Research Unit, University of Oxford, University of Oxford, University of Oxford, University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), UK Health Security Agency, Government of the United Kingdom - Oxford University Hospitals NHS Foundation Trust, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, University of Oxford - The Jenner Institute, University of Oxford - Peter Medawar Building for Pathogen Research, UK Health Security Agency - Rare & Imported Pathogens Laboratory, University of Bristol, UK Health Security Agency, University of Oxford - Nuffield Department of Clinical Medicine, University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford - Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, University of Oxford - The Jenner Institute and University of Oxford
Downloads 89 (566,765)

Abstract:

Loading...

mpox, Vaccine, MVA-BN, Transcriptomics, serology, T cell

5.

Molecular Signatures of Dengue Virus-Specific IL-10/IFN-γ Co-Producing CD4 T Cells and Their Association with Severe Dengue Disease

Number of pages: 49 Posted: 21 Aug 2019
Yuan Tian, Grégory Seumois, Luzia M. De-Oliveira-Pinto, Sara Herrera-de la Mata, Cheryl Kim, Denise Hinz, N.D. Suraj Goonawardhana, Aruna D. de Silva, Sunil Premawansa, Gayani Premawansa, Ananda Wijewickrama, Angel Balmaseda, Alba Grifoni, Pandurangan Vijayanand, Eva Harris, Bjoern Peters, Alessandro Sette and Daniela Weiskopf
La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology (LIAI) - Flow Cytometry Core Facility, La Jolla Institute for Allergy and Immunology (LIAI) - Flow Cytometry Core Facility, General Sir John Kotelawala Defense University - Department of Paraclinical Sciences, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, University of Colombo - Department of Zoology and Environment Sciences, North Colombo Teaching Hospital, National Institute of Infectious Diseases, Ministry of Health, Nicaragua - National Laboratory of Virology, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, University of California, Berkeley - Division of Infectious Diseases and Vaccinology, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery and La Jolla Institute for Immunology - Center for Infectious Disease and Vaccine Research
Downloads 80 (604,169)

Abstract:

Loading...

Dengue virus, Dengue fever, Dengue hemorrhagic fever, CD4 T cell, IL-10, IFN-γ, RNA-seq, CyTOF

6.

Single-Cell Transcriptomic Analysis of SARS-CoV-2 Reactive CD4 + T Cells

Number of pages: 39 Posted: 07 Jul 2020
Benjamin J. Meckiff, Ciro Ramírez-Suástegui, Vicente Fajardo, Serena J. Chee, Anthony Kusnadi, Hayley Simon, Alba Grifoni, Emanuela Pelosi, Daniela Weiskopf, Alessandro Sette, Ferhat Ay, Grégory Seumois, Christian Ottensmeier and Pandurangan Vijayanand
La Jolla Institute for Immunology, La Jolla Institute for Immunology, La Jolla Institute for Immunology, University of Southampton - Faculty of Medicine, La Jolla Institute for Immunology, La Jolla Institute for Immunology, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, University Hospitals NHS Foundation Trust - Southampton Specialist Virology Center, La Jolla Institute for Immunology - Center for Infectious Disease and Vaccine Research, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology (LIAI), La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Immunology and La Jolla Institute for Immunology
Downloads 77 (617,335)
Citation 10

Abstract:

Loading...

7.

Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing Sars-Cov-2 Spike: A Randomised, Comparator-Controlled, Phase 2 Trial

Number of pages: 26 Posted: 30 May 2024
Thiem Dinh Vu, Duc-Anh Dang, Vu Hai Ha, Nguyen Van Thom, Thang Cong Tran, Jose Mateus, Juan Manuel Carreño, Rama Raghunandan, Huong Mai Nguyen, Laina D. Mercer, Jorge Flores, E. Alexandar Escarrega, Ariel Raskin, Thai Huu Duong, Be Van Le, Alessandro Sette, Bruce L. Innis, Florian Krammer and Daniela Weiskopf
National Institute of Hygiene and Epidemiology, National Institute of Hygiene and Epidemiology, National Institute of Hygiene and Epidemiology, affiliation not provided to SSRN, PATH, La Jolla Institute for Immunology, affiliation not provided to SSRN, PATH, PATH, PATH, PATH, La Jolla Institute for Immunology, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, PATH, Icahn School of Medicine at Mount Sinai - Department of Microbiology and La Jolla Institute for Immunology
Downloads 33 (888,019)

Abstract:

Loading...

SARS-CoV-2, COVID-19, Newcastle disease virus, Egg-based vaccine, Phase II clinical trial

8.

Heterogeneity of Human Anti-Viral Immunity Shaped by Virus, Tissue, Age, and Sex

Number of pages: 67 Posted: 06 Jul 2021
Maya M.L. Poon, Eve Byington, Wenzhao Meng, Masaru Kubota, Rei Matsumoto, Alba Grifoni, Daniela Weiskopf, Pranay Dogra, Nora Lam, Peter A. Szabo, Basak Burcu Ural, Steven B. Wells, Aaron M. Rosenfeld, Maigan A. Brusko, Todd M. Brusko, Thomas J. Connors, Alessandro Sette, Peter A. Sims, Eline T. Luning Prak, Yufeng Shen and Donna Farber
Columbia University - Department of Microbiology and Immunology, Columbia University - Department of Systems Biology, University of Pennsylvania - Department of Pathology and Laboratory Medicine, Columbia University - Department of Surgery, Columbia University - Department of Surgery, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Immunology - Center for Infectious Disease and Vaccine Research, Columbia University - Department of Microbiology and Immunology, Columbia University Irving Medical Center - Department of Pathology and Cell Biology, Columbia University - Department of Microbiology and Immunology, Columbia University - Department of Microbiology and Immunology, Columbia University - Department of Systems Biology, University of Pennsylvania - Department of Pathology and Laboratory Medicine, University of Florida - Department of Pathology, Immunology, and Laboratory Medicine, University of Florida - Department of Pathology, Immunology, and Laboratory Medicine, Columbia University - Department of Pediatrics, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, Columbia University - Department of Systems Biology, University of Pennsylvania - Department of Pathology and Laboratory Medicine, Columbia University - Department of Systems Biology and Columbia University - Department of Microbiology and Immunology
Downloads 32 (896,727)

Abstract:

Loading...

anti-viral immunity, T cells, tissue immunity, human immunology, cytomegalovirus, influenza, immunological memory

9.

SARS-CoV-2 Breakthrough Infections Enhance T Cell Response Magnitude, Breadth and Epitope Repertoire

Number of pages: 37 Posted: 11 Jan 2024
Alison Tarke, Parham Ramezani-Rad, Tertuliano Alves Pereira Neto, Yeji Lee, Vanessa Silva-Moraes, Benjamin Goodwin, Nathaniel I. Bloom, Leila Siddaqui, Liliana Avalos, April Frazier, Zeli Zhang, Ricardo da Silva Antunes, Jennifer Dan, Shane Crotty, Alba Grifoni and Alessandro Sette
La Jolla Institute for Immunology, La Jolla Institute for Immunology, La Jolla Institute for Immunology, La Jolla Institute for Immunology, Cleveland Clinic Florida, La Jolla Institute for Immunology, La Jolla Institute for Immunology, La Jolla Institute for Immunology, La Jolla Institute for Immunology, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla Institute for Immunology - Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery and La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery
Downloads 30 (914,838)

Abstract:

Loading...

Breakthrough infection, T cells, B cells, Covid-19 vaccination, SARS-CoV-2, Delta, Omicron, de novo responses, coronavirus

10.

T Cell Reactivity to  Bordetella pertussis is Highly Diverse Regardless of Childhood Vaccination

Number of pages: 38 Posted: 04 Apr 2023
Ricardo da Silva Antunes, Emily Garrigan, Lorenzo Quiambao, Sandeep K. Dhanda, Daniel Louis Marrama, Luise Westernberg, Eric Wang, Aaron Sutherland, Sandra K. Armstrong, Timothy J. Brickman, John Sidney, April Frazier, Tod Merkel, Bjoern Peters and Alessandro Sette
La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, University of Minnesota - Minneapolis - Department of Microbiology & Immunology, University of Minnesota - Minneapolis - Department of Microbiology & Immunology, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, Government of the United States of America - Division of Bacterial, Parasitic and Allergenic Products, La Jolla Institute for Immunology and La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery
Downloads 14 (1,082,980)

Abstract:

Loading...

pertussis, T cell, epitope, antigen, ORF, accelular vaccine, whole-cell vaccine, childhood vaccination, infection, assymptomatic, polarization

11.

Asymptomatic or Symptomatic SARS-CoV-2 Infection Plus Vaccination Confers Increased Adaptive Immunity to Variants of Concern of SARS-CoV-2 Including Omicron

Number of pages: 48 Posted: 17 Jun 2022
Peifang Sun, Irene Ramos, Camila H. Coelho, Alba Grifoni, Corey A. Balinsky, Sindhu Vangeti, Alison Tarke, Nathaniel I. Bloom, Vihasi Jani, Silvia J. Jakubski, David A. Boulifard, Elizabeth Cooper, Carl Goforth, Jan J. Marayag, Amethyst Marrone, Edgar Nunez, Lindsey White, Chad K. Porter, Victor A. Sugiharto, Megan A. Schilling, Avinash S. Mahajan, Charmagne Beckett, Alessandro Sette, Stuart C. Sealfon, Shane Crotty and Andrew G. Letizia
United States Department of the Navy - Naval Medical Research Center - Silver Spring, Mount Sinai Health System - Icahn School of Medicine, La Jolla Institute for Immunology, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, United States Department of the Navy - Naval Medical Research Center - Silver Spring, Icahn School of Medicine at Mount Sinai - Department of Neurology, La Jolla Institute for Immunology, La Jolla Institute for Immunology, United States Department of the Navy - Naval Medical Research Center - Silver Spring, Government of the United States of America - Henry M. Jackson Foundation for the Advancement of Military Medicine, Government of the United States of America - Henry M. Jackson Foundation for the Advancement of Military Medicine, United States Department of the Navy - Naval Medical Research Center - Silver Spring, United States Department of the Navy - Naval Medical Research Center - Silver Spring, United States Department of the Navy - Naval Medical Research Center - Silver Spring, United States Department of the Navy - Naval Medical Research Center - Silver Spring, United States Department of the Navy - Naval Medical Research Center - Silver Spring, United States Department of the Navy - Naval Medical Research Center - Silver Spring, United States Department of the Navy - Naval Medical Research Center - Silver Spring, United States Department of the Navy - Naval Medical Research Center - Silver Spring, United States Department of the Navy - Naval Medical Research Center - Silver Spring, Mount Sinai Health System - Icahn School of Medicine, United States Department of the Navy - Naval Medical Research Center - Silver Spring, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, Icahn School of Medicine at Mount Sinai - Department of Neurology, La Jolla Institute for Immunology - Division of Vaccine Discovery and United States Department of the Navy - Naval Medical Research Center - Silver Spring
Downloads 11 (1,118,073)

Abstract:

Loading...

SARS-CoV-2, adaptive immunity, COVID-19, Asymptomatic, young adults, mild infection, long-term immunologic response

12.

Immunological Memory to Common Cold Coronaviruses Assessed Longitudinally Over a Three-Year Period

Number of pages: 36 Posted: 04 May 2022
Esther Dawen Yu, Tara M. Narowski, Eric Wang, Emily Garrigan, Jose Mateus, April Frazier, Daniela Weiskopf, Alba Grifoni, Lakshmanane Premkumar, Ricardo da Silva Antunes and Alessandro Sette
La Jolla Institute for Immunology - Center for Infectious Disease and Vaccine Research, University of North Carolina School of Medicine - Department of Microbiology and Immunology, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Immunology - Center for Infectious Disease and Vaccine Research, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Immunology - Center for Infectious Disease and Vaccine Research, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, University of North Carolina School of Medicine - Department of Microbiology and Immunology, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery and La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery
Downloads 10 (1,129,562)

Abstract:

Loading...

CD4, T cells, immune memory, common cold coronaviruses, steady state, longitudinal analysis